MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity

Ladage D et al. – Acute treatment with beta–blockers modifies local muscular metabolic properties and impairs endurance exercise capacity whereas the influence of chronic is debated controversially.

  • For the past 40 years, beta–blockers have been widely used in cardiovascular medicine, reducing morbidity as well as mortality.
  • Beta–blockers are currently used in a number of cardiovascular conditions such as systolic heart failure, postmyocardial infarction, and in prevention and treatment of arrhythmias.
  • They are not recommended as the first line antihypertensive therapy, particularly in the elderly, unless there are specific indications.
  • Despite the benefits of beta–blockers, tolerability concerns in patients with co–morbidities have limited their use.
  • Some of these problems were overcome with the discovery of cardioselective beta–blockers.
  • The third generation beta–blockers have additional properties of vasodilatation and advantages in terms of minimizing the adverse effects of beta–blockers.
  • Some of the advantages include improvement of insulin resistance, decrease in cholesterol as well as alleviation of erectile dysfunction.
[more...]